Singapore approves mpox vaccine as it adds border infection checks Unlike its close neighbour Thailand, Singapore has not yet confirmed an mpox clade Ib case. - https://lnkd.in/d2fD_7kR #pharma #mpox
Pharmaceutical-Technology
Internet News
London , England 2,249 followers
The leading site for data driven news in the pharmaceutical industry. Part of GlobalData
About us
Pharmaceutical-technology.com is one of a network of 30+ proprietary B2B websites, with an unrivalled global audience of active decision makers, influencers, and opinion leaders across the world with a combined readership of 55 million industry professionals each year. As part of GlobalData, we have access to over 1bn data points including companies, deals, projects and forecasts and trends. Leading data informs and supports our industry leading content. With expertise spanning more than 80 markets globally and driven by 800+ award-winning journalists, researchers, and analysts, we connect you with the information that makes and breaks businesses every day. Combined with our award-winning targeting technology built into our network of websites, we offer a unique end-to-end marketing solution combining insight, creativity, and cutting-edge AI-technology. Our marketing solution allows clients to identify, target and engage with prospects using access and ownership of our 30+ B2B media websites and their large sector specific audiences. With more reach, data targeting and first-party data than any other partner, we produce world-class campaigns for our clients. For more details on our technology-driven marketing solution visit www.globaldatamarketingsolutions.com
- Website
-
www.pharmaceutical-technology.com
External link for Pharmaceutical-Technology
- Industry
- Internet News
- Company size
- 501-1,000 employees
- Headquarters
- London , England
- Type
- Public Company
Locations
-
Primary
John Carpenter Street
John Carpenter House
London , England EC4Y 0AN, GB
Updates
-
Shortages improve for Eli Lilly and Company’s GLP-1 weight loss drugs, bumping sales forecast by $3bn The situation is improving for GLP-1 receptor agonist supply, particularly for Lilly’s tirzepatide products, Zepbound and Mounjaro. - https://lnkd.in/daNUHEKc #pharma #glp1 #obesitydrugs
Shortages improve for Lilly’s GLP-1 weight loss drugs, bumping sales forecast by $3bn - Pharmaceutical Technology
pharmaceutical-technology.com
-
Partner Content from World Courier - A comprehensive guide to supply chain management for specialty drugs Specialty drugs are essential in modern healthcare for treating complex or rare conditions, with a well-established supply chain critical for safe and efficient delivery. Moreover, integrating sustainable solutions within this supply chain is imperative to ensure long-term environmental and economic viability. - https://lnkd.in/gBDDn2yH #pharma #supplychain #pharmasupplychain #pharmalogistics #specialtylogistics #supplychainmanagement
A comprehensive guide to supply chain management for specialty drugs - Pharmaceutical Technology
pharmaceutical-technology.com
-
MSD snags European approval for pulmonary arterial hypertension therapy Winrevair is the first approved activin signaling pathway-targeting therapy for the treatment of the rare blood vessel disorder. - https://lnkd.in/gERfVn5u #pharma #hypertensiontherapy
MSD snags European approval for pulmonary arterial hypertension therapy - Pharmaceutical Technology
pharmaceutical-technology.com
-
UCB to divest China neurology and allergy business for $680m UCB CEO Jean-Christophe Tellier stated: “In the short term, UCB is exploring the launch of novel medicines in immunology, neurology and rare diseases in China. Our dedication to serving patients with unmet needs in China remains steadfast. Building on our 28-year presence in the country, we are committed to driving patient outcomes through continued collaboration with local partners and fostering innovation. - https://lnkd.in/grC6RH8q #pharma #neurology #allergies
UCB to divest neurology and allergy business in China for $680m
pharmaceutical-technology.com
-
Celltrion Inc’s SteQeyma receives EC approval for chronic inflammatory diseases Celltrion Europe Division senior vice-president and head Taehun Ha said: “The EC approval of SteQeyma brings an important new therapeutic option to patients and we’re excited to launch this innovative therapy, with a proven track record in Crohn’s and other immune diseases" - https://lnkd.in/dSFcaMfC #pharma #inflammatorydisease #immunediseases
Celltrion's SteQeyma gets EC approval for inflammatory diseases
pharmaceutical-technology.com
-
Licensing agreements for innovator GLP1R drugs weigh in with over $6.2bn in 2024 GLP1R agonists are currently used for the treatment of type 2 diabetes (T2D) and obesity to stimulate insulin secretion and inhibit glucagon release. - https://lnkd.in/daGq59Js #pharma #glp1r #diabetes #obesitydrugs
Licensing agreements for innovator GLP1R drugs weigh in with over $6.2bn in 2024 - Pharmaceutical Technology
pharmaceutical-technology.com
-
AstraZeneca may pull plug on UK vaccine manufacturing plans AstraZeneca may relocate its vaccine manufacturing plans from the UK to US as the finance minister discusses financing cuts. - https://lnkd.in/d7sRMFzy #pharma #vaccine #drugmanufacturing #vaccinemanufacturing #ukhealthcare
AstraZeneca may pull plug on UK vaccine manufacturing plans - Pharmaceutical Technology
pharmaceutical-technology.com
-
FDA approves updated mRNA vaccines for Covid-19 The updated mRNA Covid-19 vaccines of Pfizer and Moderna target the Omicron variant KP.2 strain. - https://lnkd.in/dy8rsS2P #pharma #covid #mrna #vaccines
FDA grants approval for updated mRNA vaccines for Covid-19
pharmaceutical-technology.com
-
Partner Content from TriLink BioTechnologies, part of Maravai LifeSciences - Enhancing mRNA drug development: how to optimise your suppliers and materials As the mRNA market booms, pharma companies seeking to commercialise in this sector can gain a competitive edge by partnering with expert suppliers - https://lnkd.in/dZwe6Q7X #pharma #mRNA #vaccines #biopharma #drugdevelopment
Enhancing mRNA drug development: how to optimise your suppliers and materials - Pharmaceutical Technology
pharmaceutical-technology.com